Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.


Journal

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
ISSN: 1532-2157
Titre abrégé: Eur J Surg Oncol
Pays: England
ID NLM: 8504356

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 01 06 2019
revised: 30 06 2019
accepted: 05 07 2019
pubmed: 16 7 2019
medline: 19 6 2020
entrez: 15 7 2019
Statut: ppublish

Résumé

Pleomorphic and Florid Lobular carcinoma in situ (P/F LCIS) are rare variants of LCIS, the exact nature of which is still debated. To collect a large series of P/F LCIS diagnosed on preoperative biopsies and evaluate their association with invasive carcinoma and high grade duct carcinoma in situ (DCIS). Data obtained were compared with those reported in the literature. A multi-institutional series of P/F LCIS was retrieved. All cases were diagnosed on pre-operative biopsies, which was followed by an open surgical excision. Data on post-operative histopathology were available. A literature review was performed. A total of 117 cases were collected; invasive carcinoma and/or DCIS was present in 78/117 cases (66.7%). Seventy cases of P/F LCIS were pure on biopsy and 31 of these showed pathological upgrade in post-surgical specimens. Pre-operative biopsy accuracy was 47/78 (60.3%); pre-operative biopsy underestimation of cancer was 31/78 (39,7.%). In the literature review papers, invasive carcinoma or DCIS was associated with 274 of 418 (65.5%) cases of P/F LCIS. Pre-operative biopsy accuracy was 66% (181/274) whereas pre-operative biopsy underestimation of cancer was 33.9% (93/274). The data presented here indicate that P/F LCIS is frequently associated with invasive carcinoma or high grade DCIS and that pre-operative biopsy is associated with an underestimation of malignancy. Open surgery is indicated when P/F LCIS is diagnosed pre-operatively.

Sections du résumé

BACKGROUND BACKGROUND
Pleomorphic and Florid Lobular carcinoma in situ (P/F LCIS) are rare variants of LCIS, the exact nature of which is still debated.
AIM OBJECTIVE
To collect a large series of P/F LCIS diagnosed on preoperative biopsies and evaluate their association with invasive carcinoma and high grade duct carcinoma in situ (DCIS). Data obtained were compared with those reported in the literature.
METHODS METHODS
A multi-institutional series of P/F LCIS was retrieved. All cases were diagnosed on pre-operative biopsies, which was followed by an open surgical excision. Data on post-operative histopathology were available. A literature review was performed.
RESULTS RESULTS
A total of 117 cases were collected; invasive carcinoma and/or DCIS was present in 78/117 cases (66.7%). Seventy cases of P/F LCIS were pure on biopsy and 31 of these showed pathological upgrade in post-surgical specimens. Pre-operative biopsy accuracy was 47/78 (60.3%); pre-operative biopsy underestimation of cancer was 31/78 (39,7.%). In the literature review papers, invasive carcinoma or DCIS was associated with 274 of 418 (65.5%) cases of P/F LCIS. Pre-operative biopsy accuracy was 66% (181/274) whereas pre-operative biopsy underestimation of cancer was 33.9% (93/274).
CONCLUSIONS CONCLUSIONS
The data presented here indicate that P/F LCIS is frequently associated with invasive carcinoma or high grade DCIS and that pre-operative biopsy is associated with an underestimation of malignancy. Open surgery is indicated when P/F LCIS is diagnosed pre-operatively.

Identifiants

pubmed: 31301938
pii: S0748-7983(19)30548-7
doi: 10.1016/j.ejso.2019.07.011
pii:
doi:

Types de publication

Journal Article Multicenter Study Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2279-2286

Informations de copyright

Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Auteurs

Maria P Foschini (MP)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Unit of Anatomic Pathology at Bellaria Hospital, Bologna (Italy). C. Baldovini present address is Anatomic Pathology Unit, Santa Maria delle Croci Hospital, Viale Randi 5, 48121, Ravenna, Italy. Electronic address: mariapia.foschini@unibo.it.

Rossella Miglio (R)

Department of Statistical Sciences, University of Bologna, Via Belle Arti 42, 40100, Bologna, Italy. Electronic address: rossella.miglio@unibo.it.

Roberta Fiore (R)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Unit of Anatomic Pathology at Bellaria Hospital, Bologna (Italy). C. Baldovini present address is Anatomic Pathology Unit, Santa Maria delle Croci Hospital, Viale Randi 5, 48121, Ravenna, Italy. Electronic address: roberta.fiore@studio.unibo.it.

Chiara Baldovini (C)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Unit of Anatomic Pathology at Bellaria Hospital, Bologna (Italy). C. Baldovini present address is Anatomic Pathology Unit, Santa Maria delle Croci Hospital, Viale Randi 5, 48121, Ravenna, Italy. Electronic address: c.baldovini@gmail.com.

Isabella Castellano (I)

Department of Medical Sciences, Pathology Unit, University of Turin, Via Santena 7, 10126, Turin, Italy. Electronic address: isabella.castellano@unito.it.

Grace Callagy (G)

Discipline of Pathology, Lambe Institute for Translational Research, NUI Galway, Costello Road, Galway, Ireland. Electronic address: grace.callagy@nuigalway.ie.

Simonetta Bianchi (S)

Department of Surgery and Translational Medicine, Section of Pathological Anatomy, Careggi University Hospital, Largo G. Alessandro Brambilla, 3, 50134, Firenze, Florence, Italy. Electronic address: Simonetta.bianchi@unifi.it.

Handan Kaya (H)

Department of Pathology, Marmara University Hospital, Istanbul, 81190, Turkey. Electronic address: hkaya@marmara.edu.tr.

Isabel Amendoeira (I)

Department of Pathology, University Hospital of S. João, Porto and Ipatimup, 4200-319, Porto, Portugal. Electronic address: isabelamendoeira@gmail.com.

Patrizia Querzoli (P)

Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, Unit of Anatomic Pathology, St Anna University Hospital, Via A. Moro 8, 44124, Ferrara, Italy. Electronic address: Patrizia.querzoli@unife.it.

Francesca Poli (F)

Pathology Unit, Ospedale Nuovo "S.Maria della Scaletta", via Montericco 4, 40026, Imola, Bologna, Italy. Electronic address: f.poli@ausl.imola.bo.it.

Cristian Scatena (C)

Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, 56126, Pisa, Italy. Electronic address: Cristian.scatena@unipi.it.

Alicia Cordoba (A)

Department of Pathology Section A, Navarra Health Service, Hospital Complex of Navarra, Irunlarrea 4, 31008, Pamplona, Spain. Electronic address: alicia.cordoba.iturriagagoitia@navarra.es.

Francesca Pietribiasi (F)

Pathology Division, Santa Croce Hospital, Vicolo Tiziano 5, 10024, Moncalieri, TO, Italy. Electronic address: pietribiasi.francesca@aslto5.piemonte.it.

Anikó Kovács (A)

Department of Clinical Pathology, Sahlgrenska University Hospital, Gothenburg, Sweden. Electronic address: aniko.kovacs@vgregion.se.

Hana Faistova (H)

The Fingerland Department of Pathology, Charles University Faculty of Medicine and University Hospital Hradec Králové, Sokolská 581, Hradec Králové, 500 03, Czech Republic. Electronic address: chiotcurieux@gmail.com.

Gábor Cserni (G)

Bacs-Kiskun County Teaching Hospital, Nyiriut 38, Kecskemet, 6000, Hungary and Department of Pathology, University of Szeged, Allomas u. 1, Szeged, 6720, Hungary. Electronic address: csernig@hotmail.com.

Cecily Quinn (C)

Department of Histopathology, St. Vincent's University Hospital, Dublin, and School of Medicine, University College, Dublin, Ireland. Electronic address: cquinn@svhg.ie.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH